149 related articles for article (PubMed ID: 36826476)
1. [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.
Adams H; van de Garde EMW; Vugts DJ; Grutters JC; Oyen WJG; Keijsers RG
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1929-1939. PubMed ID: 36826476
[TBL] [Abstract][Full Text] [Related]
2. Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Jauw YW; Zijlstra JM; de Jong D; Vugts DJ; Zweegman S; Hoekstra OS; van Dongen GA; Huisman MC
PLoS One; 2017; 12(1):e0169828. PubMed ID: 28060891
[TBL] [Abstract][Full Text] [Related]
3. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
Front Immunol; 2020; 11():617985. PubMed ID: 33584710
[TBL] [Abstract][Full Text] [Related]
4. [
Adams H; van de Garde EM; van Moorsel CH; Vugts DJ; van Dongen GA; Grutters JC; Keijsers RG
Am J Nucl Med Mol Imaging; 2019; 9(6):296-308. PubMed ID: 31976159
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
[TBL] [Abstract][Full Text] [Related]
6. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in severe, treatment-refractory interstitial lung disease.
Keir GJ; Maher TM; Ming D; Abdullah R; de Lauretis A; Wickremasinghe M; Nicholson AG; Hansell DM; Wells AU; Renzoni EA
Respirology; 2014 Apr; 19(3):353-9. PubMed ID: 24286447
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.
Sharp C; McCabe M; Dodds N; Edey A; Mayers L; Adamali H; Millar AB; Gunawardena H
Rheumatology (Oxford); 2016 Jul; 55(7):1318-24. PubMed ID: 27060110
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in connective tissue disease-associated interstitial lung disease.
Duarte AC; Cordeiro A; Fernandes BM; Bernardes M; Martins P; Cordeiro I; Santiago T; Seixas MI; Ribeiro AR; Santos MJ
Clin Rheumatol; 2019 Jul; 38(7):2001-2009. PubMed ID: 31016581
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.
Natarajan A; Habte F; Liu H; Sathirachinda A; Hu X; Cheng Z; Nagamine CM; Gambhir SS
Mol Imaging Biol; 2013 Aug; 15(4):468-75. PubMed ID: 23471750
[TBL] [Abstract][Full Text] [Related]
12.
Jauw YWS; O'Donoghue JA; Zijlstra JM; Hoekstra OS; Menke-van der Houven van Oordt CW; Morschhauser F; Carrasquillo JA; Zweegman S; Pandit-Taskar N; Lammertsma AA; van Dongen GAMS; Boellaard R; Weber WA; Huisman MC
J Nucl Med; 2019 Dec; 60(12):1825-1832. PubMed ID: 31147401
[No Abstract] [Full Text] [Related]
13. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.
Marie I; Dominique S; Janvresse A; Levesque H; Menard JF
Respir Med; 2012 Apr; 106(4):581-7. PubMed ID: 22280877
[TBL] [Abstract][Full Text] [Related]
14. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
[TBL] [Abstract][Full Text] [Related]
17. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
18.
Ledoult E; Morelle M; Soussan M; Mékinian A; Béhal H; Sobanski V; Hachulla E; Huglo D; Le Gouellec N; Remy-Jardin M; Baillet C; Launay D
Arthritis Res Ther; 2021 Mar; 23(1):76. PubMed ID: 33673861
[TBL] [Abstract][Full Text] [Related]
19. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
20. Altered splenic [
Adams H; Meek B; van de Garde EM; van Moorsel CH; Vugts DJ; Keijsers RG; Grutters JC
Am J Nucl Med Mol Imaging; 2020; 10(4):168-177. PubMed ID: 32929395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
